← All stocks

agilon health, inc.

AGL Net selling
CIK 0001831097 #2213 in the set updated 17 Sep 2026
Bought (120 mo)
$2.08M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.84B
$0.00 on a plan · $84.60M straight out of an exercise
Sold at will
$2.76B
16 of 144 sales
Net
−$2.84B
−$2.76B against sales at will

By person

26 insiders · 170 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
CD&R Investment Associates IX, Ltd. entity
10% owner
$2.75B (3)
−$2.75B
100,000,000
$60.21M
−55.5%
Desai Veeral
Chief Strategy & Dev. Officer
(1)
$32.34M (17) scheduled
−$32.34M
502,830
$302.75K
+98.5%
Shaker Benjamin
Chief Markets Officer
$301.05K (4)
$22.45M (49) scheduled
−$22.15M
122,850
$73.97K
Kornitzer Benjamin
Chief Med. & Quality Officer
(1)
$10.19M (53) scheduled
−$10.19M
62,058
$37.37K
Halkias Theodore
Chief Business Officer
$5.70M (6) scheduled
−$5.70M
105,434
$63.48K
−47.3%
Mansukani Sharad
Director
$4.53M (1) scheduled
−$4.53M
56,242
$33.86K
Sobotka Glenn
Chief Accounting Officer
$3.78M (1) scheduled
−$3.78M
5,699
$3.43K
SMITH MICHAEL L
Director
$2.85M (1)
−$2.85M
313,118
$188.53K
−29.7%
Wulf John William
Director
$149.09K (2)
$2.94M (4) scheduled
−$2.79M
16,765
$10.09K
Sell Steven
CEO & President
$614.63K (4)
$2.90M (1) scheduled
−$2.28M
929,712
$559.78K
Dombro Lisa
Exper. & Innovation Officer
$1.78M (1) scheduled
−$1.78M
11,956
$7.20K
Danieley Joan
Chief Administrative Officer
$1.14M (5) scheduled
−$1.14M
5,434
$3.27K
Richards Clay
Director
$499.10K (1)
+$499.10K
41,214
$24.81K
Gertsch Timothy
Chief Accounting Officer
$488.62K (2) scheduled
−$488.62K
14,152
$8.52K
Schwaneke Jeffrey A.
Chief Financial Officer
$250.21K (1)
+$250.21K
138,031
$83.11K
Gourdine Michelle A
Director
$115.00K (1)
+$115.00K
18,892
$11.37K
McLoughlin Karen
Director
$55.09K (1)
+$55.09K
8,207
$4.94K
Battaglia Silvana
Director
$50.27K (1)
+$50.27K
7,926
$4.77K
MCKENZIE DIANA
Director
$44.96K (2)
+$44.96K
7,633
$4.60K
Bensley Timothy
Chief Financial Officer
(1)
$0.00
39,387
$23.71K
Venkatachaliah Girish
Chief Technology Officer
(3)
$0.00
38,236
$23.02K
Zamore Denise
Chief Legal Officer
(1)
$0.00
66,075
$39.78K
O'Rourke Timothy Patrick
CEO & President
320,000
$192.67K
WILLIAMS RONALD A
Director
149,141
$89.80K
Kasenchak Priscilla
Chief Accounting Officer
7,745
$4.66K
SCHNALL RICHARD J
Director
0
$0.00

No percentages here. This company's share count has moved by a factor of 24.8 over the window, from 16,683,786 to 414,581,604 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
CD&R Investment Associates IX, Ltd.
18 May 2023
10% owner
Sell indirect
94,173,804
$20.80
$1.96B
CD&R Investment Associates IX, Ltd.
11 Aug 2022
10% owner
Sell indirect
11,337,500
$24.35
$276.07M
Shaker Benjamin
20 Jul 2022
Chief Markets Officer
Sell
4,558
$26.68
$121.61K
Shaker Benjamin
20 Jul 2022
Chief Markets Officer
Sell
45,442
$26.35
$1.20M
SMITH MICHAEL L
25 May 2022
Director
Sell indirect
145,874
$19.53
$2.85M
Shaker Benjamin
7 Apr 2022
Chief Markets Officer
Sell
2,706
$25.01
$67.68K
Wulf John William
15 Mar 2022
Director
Sell
19,708
$19.08
$376.03K
Wulf John William
15 Mar 2022
Director
Sell
11,100
$19.13
$212.34K
Shaker Benjamin
29 Dec 2021
Chief Markets Officer
Sell
4,685
$26.54
$124.34K
Shaker Benjamin
28 Dec 2021
Chief Markets Officer
Sell
14,055
$26.72
$375.55K
Shaker Benjamin
17 Nov 2021
Chief Markets Officer
Sell
4,685
$25.26
$118.34K
Shaker Benjamin
16 Nov 2021
Chief Markets Officer
Sell
4,685
$25.37
$118.86K
Shaker Benjamin
4 Nov 2021
Chief Markets Officer
Sell
18,560
$25.19
$467.53K
Shaker Benjamin
3 Nov 2021
Chief Markets Officer
Sell
300
$25.00
$7.50K
CD&R Investment Associates IX, Ltd.
14 Sep 2021
10% owner
Sell indirect
17,904,257
$28.98
$518.87M
Wulf John William
14 Sep 2021
Director
Sell
15,342
$28.98
$444.61K

What was left out

Form 4 filings counted 210
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 128
Sales at will 16
Transactions with no price 11
Shares from compensation/vesting 11,666,485
Sales filed before the plan box existed 15
History held since 16 Apr 2021